Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
The Eleventh Circuit has affirmed an attorney's fraud conviction for the second time, flatly rejecting his revived argument that the government violated his due process rights by allowing false testimony at trial in 2013.
The Florida Supreme Court on Tuesday asked a would-be medical marijuana company and the state's Department of Health to return to court for a second round of oral arguments over whether the law governing the licensing process is an unconstitutional "special law."
The Pennsylvania federal judge overseeing multidistrict litigation for price-fixing allegations in the generic drug industry has selected a case from state attorneys general to serve as a bellwether along with three private cases centered on individual drugs.
The Fifth Circuit on Monday upheld a $905,000 verdict against a Texas lab testing company sued by a Louisiana lab testing company with whom it had formerly partnered, saying neither side had a solid argument for questioning the outcome.
Given light federal regulation of cosmetics, consumers are increasingly turning to class action litigation against the cosmetics industry, so companies should carefully review manufacturing processes and marketing claims, say attorneys at Perkins Coie.